Biological Bank for the Patients Followed in a Constitutive Reference Center for Autoimmune Cytopenia
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Hospital, Bordeaux
About this trial
The Internal Medicine Department of Haut-Lévêque Hospital (Pr E LAZARO, Pr JL PELLEGRIN, Pr JF VIALLARD) was accredited in 2017 by the Ministry of Health as a Constitutive Reference Center for Autoimmune Cytopenia. The investigators wish to launch new research projects in autoimmune cytopenia and propose a translational and fundamental research based on collaboration between the clinical department, the biological resource center and the CNRS and INSERM research units ("Bedside to the Bench Strategy"). Thus, in the perspective of future research work, it seems imperative to set up a biological bank for the patients followed in our Reference Center.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients over 16 years old.
Patients with autoimmune cytopenia according to the definitions reported in the latest update of the French National Care Protocol (PNDS 2017).
Affiliated person or beneficiary of a social security scheme.
Free, informed and written consent signed by the participant and the investigator (at the latest on the day of inclusion and before any examination required by the research).
Disqualifiers
Positivity for HIV, Hepatitis C or B virus.
Pregnant or lactating woman.
Patient undergoing treatment for autoimmune cytopenia
Trial population
Patients with autoimmune cytopenia according to the definitions reported in the latest update of the French National Care Protocol (PNDS 2017).
Trial design
Design model
Case-only
Time perspective
Prospective
Treatments tested in this trial
blood sample
Biological/Vaccine45 ml whole blood for Peripheral blood mononuclear cell (PBMC) and monocytes isolation
urine sample
Biological/Vaccine12 ml
Treatment groups
200 Participants
are divided into 1 treatment groupGroup A: Autoimmune Cytopenia2 interventions
Trial outcomes
Primary outcomes
1
Number of patients with autoimmune cytopenia at diagnosis, or followed but not treated with a biological library (serum, plasma, DNA)
Time frame
At baseline (Day 0)Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University Hospital, Bordeaux
Lead sponsor
Ministry for Health and Solidarity, France
Collaborator
Source ClinicalTrials.gov